CardiaTec Biosciences
Latest round
- Seed
Last raised
- Jun 2024
Total raised
- $6.4M
Investors
- 4
About CardiaTec Biosciences
Founded in 2021 by Namshik Han (CTO), Raphael Peralta (CEO), and Thelma Zablocki (COO), and based in Cambridge, UK, CardiaTec Biosciences LTD is a target discovery platform developer that uses artificial intelligence to examine human multi-omic cardiovascular data. CardiaTec uses its patented target discovery platform, which employs artificial intelligence to comprehend large amounts of multi-omic cardiovascular data, explore target drug interactions and understand relationships between various levels of biology, including gene variation, and methylation, expression, etc. The firm explores novel aspects of patient stratification to define patient groups most compatible with the firm’s discovered targets and drugs to increase therapeutic outcomes to suit the varying needs of patients instead of offering a uniform medicine for all.
Who invested in CardiaTec Biosciences
4 investors across 1 round
See all investors in CardiaTec Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 7, 2024
Amount
$6.4M
Investors
Questions about CardiaTec Biosciences
Who invested in CardiaTec Biosciences?
CardiaTec Biosciences has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CardiaTec Biosciences raised?
CardiaTec Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CardiaTec Biosciences last raise money?
CardiaTec Biosciences's most recent round on record is a Seed, in Jun 2024.
What does CardiaTec Biosciences do?
Founded in 2021 by Namshik Han (CTO), Raphael Peralta (CEO), and Thelma Zablocki (COO), and based in Cambridge, UK, CardiaTec Biosciences LTD is a target discovery platform developer that uses artificial intelligence to examine human multi-omic cardiovascular data.
Where is CardiaTec Biosciences headquartered?
CardiaTec Biosciences is headquartered in Cambridge, UK.
Which VCs invest in companies like CardiaTec Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at CardiaTec Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CardiaTec Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.